HomeAI · summaries
Storia in 7 fonti
GC Biopharma sells US vaccine unit to Eli Lilly in $1.5b deal
GC Biopharma said Wednesday that it would transfer its US affiliate Curevo Vaccine to Eli Lilly and Company in a deal worth up to $1.5 billion. Under the agreem
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
qz.com
Eli Lilly acquires three vaccine developers for $3.8 billion
The deals give Lilly vaccines targeting shingles, bacterial pathogens, and Epstein-Barr virus as it expands beyond weight loss drugs
- ·
endpoints.news
Three vaccine biotechs to be bought by Lilly for up to $3.8B
Lilly is making three acquisitions at once on Tuesday, for up to $3.8 billion total, to increase its presence in infectious disease. The pharma is buying Curevo, LimmaTech…
- ·
cnbc.com
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
- ·
pharmaceutical-technology.com
Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology
Via the deals, Lilly is buying biotechs with lead programmes in preventing shingles, bacteria, and Epstein-Barr Virus.
- ·
axios.com
Eli Lilly spending $3.8 billion to buy vaccine makers
GLP-1 riches are being repurposed to prevent infections.
- ·
upi.com
Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - UPI.com
Eli Lilly announced Tuesday that it is acquiring Curevo Inc., LimmaTech Biologics AG and Vaccine Company, Inc., in deals totaling nearly $4 billion.
- ·
koreaherald.com
GC Biopharma sells US vaccine unit to Eli Lilly in $1.5b deal
GC Biopharma said Wednesday that it would transfer its US affiliate Curevo Vaccine to Eli Lilly and Company in a deal worth up to $1.5 billion. Under the agreem